The U.S. Centers for Medicare & Medicaid Services (CMS) Tuesday asked the White House to review a hospital payment proposed rule for next year that will either keep, end, or change the nearly 30 percent cut since 2018 in Medicare
…
Category: Federal
DOJ Cites 1996 HRSA Letter to PhRMA in Request to Dismiss Novo Nordisk’s 340B Contract Pharmacy Suit
Novo Nordisk’s claim that a federal legal advisory opinion on 340B contract pharmacy would make it unlawfully transfer its drugs to ineligible pharmacies and ineligible patients “is mere legerdemain” (slight of hand), government lawyers for U.S. Health and Human Services
…
The U.S. Senate on Wednesday voted 61-37 to confirm Andrea Palm’s nomination to be deputy secretary for the U.S. Department of Health and Human Services (HHS). Palm voiced support for the 340B program during her confirmation hearing.
Palm’s confirmation still
…Breaking News
Breaking: Becerra, on 340B Pricing Denials, Tells House Panel, “Everyone Has to Follow the Law”
U.S. Health and Human Services (HHS) Secretary Xavier Becerra told a member of Congress during a hearing this morning “We are on this one” when asked about six drug manufacturers’ denials of 340B drug discounts when covered entities use contract
…
The U.S. Health Resources and Services Administration (HRSA) yesterday asked the White House for permission to rescind the Trump administration’s final rule to require health centers to provide insulin and injectable epinephrine to low-income patients at the price the centers
…
There is a 340B angle in the fight in the U.S. House over who should be third in the Republican leadership ranks.
The GOP caucus is expected to vote tomorrow to remove Rep. Liz Cheney (R-Wyo.) as House Republican Conference
…
Drug manufacturer Eli Lilly yesterday asked a federal district judge in Indianapolis to schedule oral argument as soon as mid-June in its lawsuit challenging both a federal legal advisory opinion about 340B contract pharmacy and the 340B program’s new administrative
…
The plain language of the 340B statute “explicitly requires drug manufacturers to offer 340B discounts to 340B covered entities regardless of whether the drugs are dispensed by the entity or by an outside pharmacy with which the entity has a
…
A powerful U.S. House health subcommittee has invited U.S. health secretary Xavier Becerra to brief it next week about his department’s discretionary budget request for the coming fiscal year, and to discuss how they might collaborate on lowering drug prices
…